Field Trip Health & Wellness Ltd. (TSX-V: FTHW) ("Field Trip"
or the “Company”), the global leader in the development and
delivery of psychedelic therapies, is pleased to announce that a
new version of its award-winning app for psychedelic guidance is
now available for download on the App Store and Google Play.
Formerly known as ‘Trip’ and now known simply as
‘Field Trip’, the app, which has been downloaded over 80,000 times,
includes a number of new features, such as offline access to music
and meditations, higher bit-rate streaming, access to Field Trip’s
therapeutic programs, and a new user flow.
In addition, Field Trip will soon include six
exclusive tracks from Wavepaths, the global leader in music
solutions for psychedelic therapy. These tracks were exclusively
developed for Field Trip’s in-person psychedelic-assisted
therapies, and will be made available through the app in the coming
weeks.
“We are incredibly excited to release the ‘Field
Trip’ app,” said Mujeeb Jafferi, Field Trip’s President. “For one,
its new features and content, including the exclusive Wavepaths
tracks, make it an even better companion for psychedelic
experiences. Furthermore, it marks the first step in Field Trip’s
evolution as a company. We set out to prove that the medical
profession and society at-large were ready to re-embrace
psychedelics. We have done that. Our strategy now is to engage as
many people as possible in conversations around these powerful
compounds and experiences, with the Field Trip app as the focal
point for that strategy, supported by our Field Trip locations
around the world.”
In the coming months, Field Trip plans to
announce new initiatives that it expects will greatly expand access
to, and education around the use of, psychedelics. These will
include new and innovative therapeutic programs utilizing legal
psychedelic compounds and non-ordinary states of consciousness, and
an accelerated development program for the Field Trip app. In
preparation for these new programs, the Company expects to
restructure the staffing and operations at the Atlanta, Houston and
Amsterdam locations, which may delay the acceptance of new clients
at such locations.
“For the first three years of our existence, our
operational focus was on building the clinical infrastructure to
deliver psychedelic therapies in response to the mental health
crisis,” said Ronan Levy, Field Trip’s Chairman and CEO. “In the
process, we developed the most recognized voice and brand in the
industry1 and built a global community for the millions of people
who are interested in psychedelics.2”
“We aspire to be the center of gravity for the
psychedelic movement which is growing exponentially,” Levy added.
“And so, we are leaning into that as our strategy going
forward.”
About Field Trip Health & Wellness
Ltd.
With a large global community of
psychedelic-interested people, proprietary psychedelic therapies
generating transformative results for people in the treatment of
mental health conditions and a brand and share of voice that is
reaching millions of people, Field Trip is a center of gravity for
the psychedelic renaissance.
Learn more at https://www.meetfieldtrip.com,
https://www.fieldtriphealth.com and
https://www.fieldtriphealth.nl.
Follow us on Twitter and Instagram:
@fieldtriphealth
To receive company updates about Field Trip and
to be added to the email distribution list please sign up here.
Download Field Trip’s app here.
Cautionary Note Regarding
Forward-Looking Information.
This release includes forward-looking
information (within the meaning of Canadian securities laws)
regarding the Company and its business. Often but not always,
forward-looking information can be identified by the use of words
such as "expect", "intends", "anticipated", "believes" or
variations (including negative variations) of such words and
phrases, or state that certain actions, events or results "may",
"could", "would" or "will" be taken, occur or be achieved. Such
statements are based on the current expectations and views of
future events of the management of the Company and are based on
assumptions and subject to risks and uncertainties. Although the
management believes that the assumptions underlying these
statements are reasonable, they may prove to be incorrect. The
forward-looking events and circumstances discussed in this release
may not occur and could differ materially as a result of known and
unknown risk factors and uncertainties affecting the companies,
including downloads, engagement, reviews, and use of the Field Trip
application by users. Although the Company has attempted to
identify important factors that could cause actual actions, events
or results to differ materially from those described in
forward-looking statements, there may be other factors that cause
actions, events or results to differ from those anticipated,
estimated or intended. Accordingly, readers should not place undue
reliance on any forward-looking statements or information. No
forward-looking statement can be guaranteed. Except as required by
applicable securities laws, forward-looking statements speak only
as of the date on which they are made and the Company does not
undertake any obligation to publicly update or revise any
forward-looking statement, whether as a result of new information,
future events, or otherwise. Additional information relating to the
Company, can be located on the SEDAR website at www.sedar.com .
This press release does not constitute an offer
to sell or the solicitation of an offer to buy securities.
Neither the TSX Venture Exchange nor its
Regulation Services Provider, have approved the contents of this
release or accept responsibility for the adequacy or accuracy of
this release.
CONTACTS:
Field Trip Health &
Wellness:
Ronan Levy
Chairman & CEO
(416) 505-0929
ronan@fieldtriphealth.com
Media contacts:
Rachel Moskowitz
Autumn Communications
(202) 276-7881
press@fieldtriphealth.com
Investor contacts:
Phil Carlson / Sophia Bashford
(646) 573-0776 / (929) 246-7307
KCSA Strategic Communications
fieldtripIR@kcsa.com
SOURCE Field Trip Health & Wellness Ltd.
1 Per Meltwater Share of Voice Calculation YTD.2NIDA. 2021,
August 3. References. Retrieved from
https://nida.nih.gov/publications/research-reports/hallucinogens-dissociative-drugs/references
on 2022, October 12
Field Trip Health and We... (TSXV:FTHW)
Historical Stock Chart
From Apr 2024 to May 2024
Field Trip Health and We... (TSXV:FTHW)
Historical Stock Chart
From May 2023 to May 2024